Frontlight ResearchEarly access
Trial site
Jiangxi maternal and child health hospital
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Endometrial cancer6 trials
- Ovarian cancer5 trials
- Cervical cancer3 trials
- Lung cancer2 trials
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Mesothelioma1 trial
- Triple-negative breast cancer1 trial
- Uterine fibroids1 trial
- Phase
- Phase 39 trials
- Phase 1/22 trials
- Phase 22 trials
- Status
- Recruiting6 trials
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Daiichi Sankyo2 trials
- Bayer1 trial
- BeiGene1 trial
- BioNTech SE1 trial
- DualityBio Inc.1 trial
- and 7 more
Running trials
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer4 recruiting
- Cervical cancer3 recruiting
- Ovarian cancer3 recruiting
- Lung cancer2 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mesothelioma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Site data: ClinicalTrials.govUpdated 17 Nov 2026